Ive heard about a treatment for autism called secretin. What is the Yale Child Study Centers policy on secretin?
We at the Yale Child Study Center Autism Research Group watched the “Dateline NBC” program about secretin on 10/7/98 with interest. Immediately after the program was aired, we were receiving requests for information about the efficacy of this drug for treating autism. Now, literature has begun to appear detailing the results of controlled clinical trials of secretin. Currently, researchers at the University of Chicago, University of Utah and University of California-Irvine are conducting a multi-site trial to determine its efficacy. There are also related trials being conducted at the University of Colorado and University of Washington. The first results from the multi-site study have been published by Thomas Owley, MD, Elisa Steele, MS, Christina Corsello, MA, Susan Risi, PhD, Kathryn McKaig, MS, Catherine Lord, PhD, Bennett L. Leventhal, MD, and Edwin H. Cook Jr, MD, and you can view them on Medscape. Using a double-blind, placebo-controlled design, they found no significant differen
